# Real‐world insights on switching aflibercept dosage for enhanced outcomes in age‐related macular degeneration ( <scp>RISE</scp> ‐ <scp>AMD</scp> ): Safety data

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-insights-on-switching-aflibercept-dosage-for-enhanced-outcomes-in-age/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mary Graciya Karunainathan,Celine Lee,Kaweh Daniel Zohalinejad,Mads Odgaard Mæng,Nanna Würtz Fabrin,Sigurros Jonsdottir,Anne Kjærsgaard Hassing,Søren Kveiborg Yde,Charles C. Wykoff,Henrik Vorum,Yousif Subhi,Marie Ørskov,Lasse Jørgensen Cehofski |
| Citations | 0 |
| DOI | 10.1111/aos.70160 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1111/aos.70160 |
| OpenAlex ID | https://openalex.org/W7162501854 |
| PMID | 42199036 |
| Type | article |
| Year | 2026 |

## Paper authors

- [Anne Kjærsgaard Hassing](https://scholariq.org/researchers/anne-kj-rsgaard-hassing/)

## Paper journal

- [Acta Ophthalmologica](https://scholariq.org/journals/acta-ophthalmologica/)

## Paper primary topic

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

## Paper topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Ophthalmology and Visual Impairment Studies](https://scholariq.org/topics/ophthalmology-and-visual-impairment-studies/)
- [Glaucoma and retinal disorders](https://scholariq.org/topics/glaucoma-and-retinal-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.